Advance the science of programmable bioelectric medicine alongside the labs and networks defining the field.
Clinical and healthcare partners.
Bring programmable bioelectric medicine into the workflows where chronic pain is actually managed.
Electrome partners with health systems, ambulatory surgery centers, orthopedic groups, rehabilitation networks, pain clinics, and federal health channels to integrate FDA-cleared bioelectric therapy into existing care pathways. Partnerships span clinical pilots, formulary inclusion, perioperative protocols, recovery programs, and managed care evaluations.
What partners get
Drug-free pain pathway
An FDA-cleared, non-opioid, non-thermal therapy that fits inside opioid stewardship, ERAS, and conservative-care-first protocols.
Workflow ready
Documentation, dosing, and patient instructions designed for clinic, perioperative, and home-use handoffs without disrupting existing rooms or staff.
Patient adherence
Wearable form factor and continuous-wear protocols are designed to support adherence between visits, so the therapy keeps working after the patient leaves the clinic.
Evidence-aligned
Backed by peer-reviewed PSWT and PEMF literature spanning multiple indications, with clinical evidence summaries available to formulary and P&T committees on request.
How partnerships show up
Examples of the partnership shapes that fit this category. Most engagements blend more than one.
Perioperative recovery
Integrate into pre-op and post-op protocols to support recovery without adding pharmacological load.
Chronic musculoskeletal pain
A take-home option for orthopedic, rheumatology, and physiatry patients managing chronic joint and soft tissue pain.
Conservative care escalation
Slot in before injection or surgical escalation for patients whose conservative care has plateaued.
Federal and VA pathways
Designed to align with VA pain management directives and the federal push for non-opioid alternatives.
Partner archetypes
The kinds of organizations we partner with in this category. We are happy to share specific named relationships under standard partnership review.
Frequently asked
Reimbursement pathways depend on payer, indication, and care setting. Our team works with partner health systems to evaluate coding, coverage, and patient pay options on a program-by-program basis.
We can share peer-reviewed PSWT and PEMF literature, indication-specific trial summaries, and FDA 510(k) clearance documentation under standard partnership review.
Yes. The therapy is designed for continuous-wear use across clinic and home settings, with patient instructions written for both.
Ready to talk?
Tell us a little about the program you have in mind. The partnerships team will route it to the right clinical, commercial, or technical lead.
Other partner categories
Bring FDA-cleared bioelectric pain therapy to the shelves, channels, and platforms where patients already shop for relief.
Build alongside the platform layer connecting pulsed shortwave therapy research to programmable, AI-native, human-in-the-loop infrastructure for bioelectric medicine.
